Published in Dig Dis Sci on February 01, 1998
Dietary Triggers of Gastrointestinal Symptoms in IBS Patients | NCT03664531
Efficacy and Safety of IBS Digital Behavioral Treatment (EASITx) | NCT04133519
Prevalence of Antihistamine Responsive Irritable Bowel Syndrome With Diarrhea | NCT04612803
Visceral Sensitivity in Women With BS and Sexual Dysfunction (IBS) | NCT04716738
Neurocognitive Effects of FMT in MDD Patients With and Without IBS | NCT05174273
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ (2009) 2.51
A treatment trial of acupuncture in IBS patients. Am J Gastroenterol (2009) 2.41
A randomised controlled trial of self-help interventions in patients with a primary care diagnosis of irritable bowel syndrome. Gut (2005) 2.11
International survey of patients with IBS: symptom features and their severity, health status, treatments, and risk taking to achieve clinical benefit. J Clin Gastroenterol (2009) 2.06
Prevalence of irritable bowel syndrome: a community survey. Br J Gen Pract (2004) 2.03
Psychosocial aspects of the functional gastrointestinal disorders. Gut (1999) 1.99
Acupuncture for irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol (2012) 1.76
IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. Am J Gastroenterol (2011) 1.72
Adequate relief in a treatment trial with IBS patients: a prospective assessment. Am J Gastroenterol (2009) 1.64
Randomised controlled trial of mesalazine in IBS. Gut (2014) 1.58
Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease. PLoS One (2015) 1.52
Colonic mucosal immune activity in irritable bowel syndrome: comparison with healthy controls and patients with ulcerative colitis. Dig Dis Sci (2013) 1.48
Quality of life measurement in gastrointestinal and liver disorders. Gut (2000) 1.44
Text messaging: an innovative method of data collection in medical research. BMC Res Notes (2010) 1.32
The impact of rotating shift work on the prevalence of irritable bowel syndrome in nurses. Am J Gastroenterol (2010) 1.26
A cluster randomised controlled trial of the clinical and cost-effectiveness of a 'whole systems' model of self-management support for the management of long- term conditions in primary care: trial protocol. Implement Sci (2012) 1.23
Design of treatment trials for functional gastrointestinal disorders. Gut (1999) 1.23
A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations. Behav Res Ther (2011) 1.18
Measuring irritable bowel syndrome patient-reported outcomes with an abdominal pain numeric rating scale. Aliment Pharmacol Ther (2009) 1.16
Translation and validation of a Japanese version of the irritable bowel syndrome-quality of life measure (IBS-QOL-J). Biopsychosoc Med (2007) 1.15
Diagnosis and management of IBS. Nat Rev Gastroenterol Hepatol (2010) 1.14
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Epidemiology of irritable bowel syndrome in Chinese. Dig Dis Sci (2002) 1.12
Anxiety, depression and quality of life in patients with irritable bowel syndrome. Gut Liver (2011) 1.12
Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol (2014) 1.10
Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol (2010) 1.09
Patient-reported outcomes in gastroenterology: clinical and research applications. J Neurogastroenterol Motil (2013) 1.07
Qualitative development of a patient-reported outcome symptom measure in diarrhea-predominant irritable bowel syndrome. Clin Transl Gastroenterol (2014) 1.07
Patients with irritable bowel syndrome exhale more hydrogen than healthy subjects in fasting state. J Neurogastroenterol Motil (2010) 1.07
Recommendations on chronic constipation (including constipation associated with irritable bowel syndrome) treatment. Can J Gastroenterol (2007) 1.07
Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr (2015) 1.07
Evaluation of the Birmingham IBS symptom questionnaire. BMC Gastroenterol (2008) 1.06
Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev (2012) 1.05
Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. Clin Gastroenterol Hepatol (2007) 1.04
Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations. J Behav Med (2011) 1.04
Cross-cultural validation of Irritable Bowel Syndrome Quality of Life in Korea. Dig Dis Sci (2006) 1.04
Evaluation of health related quality of life in irritable bowel syndrome patients. Health Qual Life Outcomes (2012) 1.03
Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial. Br J Gen Pract (2006) 1.01
Familial aggregation of irritable bowel syndrome: a family case-control study. Am J Gastroenterol (2010) 0.99
Homeopathy--what are the active ingredients? An exploratory study using the UK Medical Research Council's framework for the evaluation of complex interventions. BMC Complement Altern Med (2006) 0.97
Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol (2011) 0.97
Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol (2014) 0.97
Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil (2008) 0.96
A focus group assessment of patient perspectives on irritable bowel syndrome and illness severity. Dig Dis Sci (2009) 0.96
A cross-sectional study of the association between overnight call and irritable bowel syndrome in medical students. Can J Gastroenterol (2012) 0.95
Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort. Am J Gastroenterol (2009) 0.95
Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial). BMC Gastroenterol (2010) 0.94
Pattern of irritable bowel syndrome and its impact on quality of life in primary health care center attendees, Suez governorate, Egypt. Pan Afr Med J (2011) 0.94
Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina. Dig Dis Sci (2007) 0.93
Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol (2014) 0.93
Mindfulness for irritable bowel syndrome: protocol development for a controlled clinical trial. BMC Complement Altern Med (2009) 0.92
Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci (2011) 0.91
Child and parent perceived food-induced gastrointestinal symptoms and quality of life in children with functional gastrointestinal disorders. J Acad Nutr Diet (2013) 0.89
Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice. Aliment Pharmacol Ther (2010) 0.89
The effect of tegaserod on symptoms and quality of life in korean women with irritable bowel syndrome with constipation. J Neurogastroenterol Motil (2010) 0.89
Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual Life Outcomes (2013) 0.88
A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. BMC Gastroenterol (2013) 0.87
The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci (2012) 0.87
Irritable bowel syndrome. BMJ Clin Evid (2012) 0.87
Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation. World J Gastroenterol (2015) 0.86
Health related quality of life in functional gastrointestinal disorders in Asia. J Neurogastroenterol Motil (2011) 0.86
A randomized controlled trial of anorectal biofeedback for constipation. Int J Colorectal Dis (2011) 0.86
Travel and travelers' diarrhea in patients with irritable bowel syndrome. Am J Trop Med Hyg (2010) 0.85
Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study. J Gastroenterol (2016) 0.83
Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes (2015) 0.83
Obstetric sphincter injury interacts with diarrhea and urgency to increase the risk of fecal incontinence in women with irritable bowel syndrome. Female Pelvic Med Reconstr Surg (2013) 0.82
Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapy. World J Gastroenterol (2014) 0.82
The effects of lifestyle modification on symptoms and quality of life in patients with irritable bowel syndrome: a prospective observational study. Gut Liver (2011) 0.82
Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website. BMC Gastroenterol (2013) 0.81
Visceral sensitivity as a mediator of outcome in the treatment of irritable bowel syndrome. Behav Res Ther (2012) 0.81
Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. Dig Dis Sci (2007) 0.81
Snapshot of an integrated psychosocial gastroenterology service. World J Gastroenterol (2015) 0.81
Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database. Am J Gastroenterol (2013) 0.80
The ties that bind: perceived social support, stress, and IBS in severely affected patients. Neurogastroenterol Motil (2010) 0.79
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation. United European Gastroenterol J (2015) 0.79
Validity, reliability, and factor analysis of Persian version of quality of life questionnaire for irritable bowel syndrome (IBS-QOL-34). J Res Med Sci (2013) 0.79
Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil (2014) 0.79
Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory. Int J Colorectal Dis (2014) 0.79
Psychological therapies in patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials. Gastroenterol Res Pract (2015) 0.78
A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study). BMC Gastroenterol (2011) 0.78
Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation. Health Qual Life Outcomes (2016) 0.78
Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes (2013) 0.78
Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol (2016) 0.78
Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea. Frontline Gastroenterol (2010) 0.78
Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. Biopsychosoc Med (2016) 0.77
Nutrition Quality of Life among Female-Majority Malay Undergraduate Students of Health Sciences. Malays J Med Sci (2012) 0.77
Group counseling psychotherapy for patients with functional gastrointestinal disorders: development of new measures for symptom severity and quality of life. Dig Dis Sci (2002) 0.77
Irritable bowel syndrome. BMJ Clin Evid (2010) 0.77
Changes in duodenal enteroendocrine cells in patients with irritable bowel syndrome following dietary guidance. Exp Biol Med (Maywood) (2017) 0.76
Aspects of certainty in patient classification using a health-related quality-of-life instrument in inflammatory bowel disease. Proc AMIA Symp (1999) 0.76
Study design considerations for irritable bowel syndrome clinical trials. Ann Gastroenterol (2014) 0.76
Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome. BMC Gastroenterol (2013) 0.76
Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients. Neurogastroenterol Motil (2016) 0.76
The effects of multi-strain probiotic compound on symptoms and quality-of-life in patients with irritable bowel syndrome: A randomized placebo-controlled trial. Adv Biomed Res (2014) 0.76
Stomach antral endocrine cells in patients with irritable bowel syndrome. Int J Mol Med (2014) 0.76
Health related quality of life in irritable bowel syndrome patients, Kashan, Iran: A case control study. Adv Biomed Res (2015) 0.76
Moxibustion treatment for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial. BMC Complement Altern Med (2016) 0.75
A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Res Int (2016) 0.75
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
Measuring health-related quality of life. Ann Intern Med (1993) 11.84
U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci (1993) 7.98
Assessing health-related quality of life in patients with sciatica. Spine (Phila Pa 1976) (1995) 7.23
A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology (1989) 4.27
Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology (1988) 4.06
Medical costs in community subjects with irritable bowel syndrome. Gastroenterology (1995) 2.81
Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology (1988) 2.76
Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology (1997) 2.71
Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol Med (1991) 2.46
Health status by gastrointestinal diagnosis and abuse history. Gastroenterology (1996) 2.41
Impact of irritable bowel syndrome on quality of life. Dig Dis Sci (1996) 1.81
Quality of life of persons with urinary incontinence: development of a new measure. Urology (1996) 1.74
Quality of life assessment by patients with inflammatory bowel disease. Cleve Clin J Med (1992) 1.55
The rating form of IBD patient concerns: a new measure of health status. Psychosom Med (1992) 1.46
Functional bowel disorders. A multicenter comparison of health status and development of illness severity index. Dig Dis Sci (1995) 1.35
[The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery]. Chirurg (1993) 1.24
Physical symptom severity, psychological and social dysfunction in a series of outpatients with irritable bowel syndrome. J Psychosom Res (1990) 1.20
Towards a better understanding of patients with irritable bowel syndrome. J Adv Nurs (1993) 0.93
Measuring health-related quality of life in persons with genital herpes. Qual Life Res (1995) 0.87
Irritable bowel syndrome. Gastroenterologist (1994) 0.80
Functional bowel disorders and functional abdominal pain. Gut (1999) 7.63
Detection of coliform bacteria in water by polymerase chain reaction and gene probes. Appl Environ Microbiol (1990) 4.89
The irritable bowel syndrome. Gastroenterology (1977) 4.64
Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction. Gastroenterology (1982) 4.46
Detection of Legionella with polymerase chain reaction and gene probe methods. Mol Cell Probes (1990) 3.83
Medical interviewing and interpersonal skills teaching in US medical schools. Progress, problems, and promise. JAMA (1993) 2.37
Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology (1984) 2.24
Quality of life of women with urinary incontinence: further development of the incontinence quality of life instrument (I-QOL) Urology (1999) 2.21
Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology (1987) 1.84
Safety and patient outcomes with lubiprostone for up to 52 weeks in patients with irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2012) 1.83
Sexual and physical abuse history in gastroenterology practice: how types of abuse impact health status. Psychosom Med (1996) 1.74
Selected symptoms associated with sexual and physical abuse history among female patients with gastrointestinal disorders: the impact on subsequent health care visits. Psychol Med (1998) 1.74
A national survey of practice patterns of gastroenterologists with comparison to the past two decades. J Clin Gastroenterol (1999) 1.73
Bowel habits in young adults not seeking health care. Dig Dis Sci (1987) 1.72
Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist. Aliment Pharmacol Ther (1999) 1.66
Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation. Aliment Pharmacol Ther (2008) 1.50
Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med (1997) 1.50
The problem patient. Evaluation and care of medical patients with psychosocial disturbances. Ann Intern Med (1978) 1.49
The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease. Int J Geriatr Psychiatry (1997) 1.46
Validity of the Family APGAR in patients with irritable bowel syndrome. Fam Med (1993) 1.45
Correlates of recreational physical activity in early pregnancy. J Matern Fetal Neonatal Med (2003) 1.44
The reliability and validity of a sexual and physical abuse history questionnaire in female patients with gastrointestinal disorders. Behav Med (1995) 1.37
Irritable bowel syndrome. Annu Rev Med (2001) 1.36
Urgency and fecal soiling in people with bowel dysfunction. Dig Dis Sci (1986) 1.27
Impact of sexual and physical abuse dimensions on health status: development of an abuse severity measure. Psychosom Med (1997) 1.26
Gastrointestinal illness and the biopsychosocial model. J Clin Gastroenterol (1996) 1.19
Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation. Neurogastroenterol Motil (2014) 1.19
Utility of red flag symptom exclusions in the diagnosis of irritable bowel syndrome. Aliment Pharmacol Ther (2006) 1.17
Cross-cultural variation in disease-related concerns among patients with inflammatory bowel disease. Am J Gastroenterol (2001) 1.16
Health-care-seeking behaviors related to bowel complaints. Hispanics versus non-Hispanic whites. Dig Dis Sci (1996) 1.11
The usual medical care for irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.11
Cholesterol and coronary heart disease: predicting risks in men by changes in levels and ratios. J Investig Med (1995) 1.11
Concerns of patients with inflammatory bowel disease: a review of emerging themes. Dig Dis Sci (2000) 1.07
Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life. Scand J Gastroenterol (2003) 1.06
Recollection of childhood events in adults with irritable bowel syndrome. J Clin Gastroenterol (1987) 1.03
Health-related quality of life after ileoanal pull-through evaluation and assessment of new health status measures. Gastroenterology (1997) 1.01
Patients with psychogenic abdominal pain: six years' observation in the medical setting. Am J Psychiatry (1982) 0.98
Is functional dyspepsia just a subset of the irritable bowel syndrome? Baillieres Clin Gastroenterol (1998) 0.96
Small intestinal bacterial overgrowth in irritable bowel syndrome: association with colon motility, bowel symptoms, and psychological distress. Neurogastroenterol Motil (2008) 0.96
Psychologic and psychiatric aspects of gastrointestinal disease. Med Clin North Am (2000) 0.96
Teaching psychosomatic (biopsychosocial) medicine in United States medical schools: survey findings. Psychosom Med (2001) 0.96
Sexual and physical abuse are not associated with rectal hypersensitivity in patients with irritable bowel syndrome. Gut (2004) 0.96
Challenges in the physician-patient relationship: feeling "drained". Gastroenterology (2001) 0.94
Psychosocial aspects of Crohn's disease. Surg Clin North Am (2001) 0.93
Review article: the functional abdominal pain syndrome. Aliment Pharmacol Ther (2011) 0.93
Health status in inflammatory bowel disease. Biological and behavioral considerations. Gastroenterology (1990) 0.92
The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment Pharmacol Ther (2009) 0.92
Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project. Am J Psychiatry (1994) 0.91
Centrally targeted pharmacotherapy for chronic abdominal pain. Neurogastroenterol Motil (2015) 0.90
Diagnosis and treatment of irritable bowel syndrome. Drugs Today (Barc) (1998) 0.89
The Rome criteria process: diagnosis and legitimization of irritable bowel syndrome. Am J Gastroenterol (1999) 0.89
Irritable bowel syndrome: epidemiology, diagnosis and treatment. Clin Gastroenterol (1985) 0.89
The relationship of psychiatric illness with gastrointestinal disease. Annu Rev Med (1995) 0.89
Constipation does not develop following elective hysterectomy: a prospective, controlled study. Neurogastroenterol Motil (2009) 0.88
The patient with chronic undiagnosed abdominal pain. Hosp Pract (Off Ed) (1986) 0.85
The role of the attending physician. Arch Intern Med (1982) 0.85
Diagnosis and treatment of irritable bowel syndrome. Am Fam Physician (1997) 0.84
The role of psychosocial factors in irritable bowel syndrome. Baillieres Best Pract Res Clin Gastroenterol (1999) 0.84
Selective recall of gastrointestinal-sensation words: evidence for a cognitive-behavioral contribution to irritable bowel syndrome. Am J Gastroenterol (2001) 0.83
Factor analysis of bowel symptoms in US and Italian populations. Dig Liver Dis (2003) 0.83
Psychosocial factors in gastrointestinal illness. Psychother Psychosom (1993) 0.82
Comparison of bowel patterns in Hispanics and non-Hispanic whites. Dig Dis Sci (1995) 0.80
A prospective economic evaluation of basiliximab (Simulect) therapy following renal transplantation. Clin Transplant (2000) 0.80
Newer aspects of the irritable bowel syndrome. Prim Care (1996) 0.79
A current approach to acute upper gastrointestinal bleeding. J Clin Gastroenterol (1981) 0.79
Psychosocial treatment of the refractory patient with irritable bowel syndrome. J Clin Gastroenterol (1987) 0.79
Maternal recreational physical activity is associated with plasma leptin concentrations in early pregnancy. Hum Reprod (2004) 0.78
Development and pilot testing of an integrated, web-based self-management program for irritable bowel syndrome (IBS). Neurogastroenterol Motil (2014) 0.77
Clinical conference. Anorexia nervosa. Gastroenterology (1979) 0.77
Use of psychotropic drugs in patients with peptic ulcer. Psychosomatics (1985) 0.77
Clinical research in the functional digestive disorders. Gastroenterology (1987) 0.77
From gut to brain and back--a new perspective into functional gastrointestinal disorders. J Psychosom Res (1999) 0.77
Cost of treating an episode of variceal bleeding in a VA setting. Am J Gastroenterol (2000) 0.77
Psychosocial factors in inflammatory bowel disease. Gastroenterol Clin North Am (1995) 0.77
Sexual and physical abuse history and medical practice. Gen Hosp Psychiatry (1995) 0.76
How multiple types of stressors impact on health. Psychosom Med (1998) 0.76
Is the cotton-topped tamarin a model for behavioral research? Dig Dis Sci (1985) 0.75
Health economics with retrospective data: selection bias issues. J Int Med Res (1997) 0.75
Commentary: short-term stability of subtypes in the irritable bowel syndrome. Aliment Pharmacol Ther (2012) 0.75
Gastrointestinal diagnosis, abuse history, and effects on health status. Gastroenterology (1996) 0.75
Treatment of patients with functional esophageal symptoms: is there a role for a psychotherapeutic approach? J Clin Gastroenterol (1999) 0.75
Placebo controlled study randomizing leuprolide acetate. Dig Dis Sci (1995) 0.75
Irritable bowel syndrome: how far do you go in the workup? Gastroenterology (2001) 0.75
Hepatobiliary disease that precedes ulcerative colitis. J Clin Gastroenterol (1984) 0.75
A current approach to rectal bleeding. J Clin Gastroenterol (1981) 0.75
Patients with the irritable bowel syndrome: seeing the forest for the trees (or how not to bark up the wrong tree) J Clin Gastroenterol (1983) 0.75
Hemobilia complicating warfarin therapy. South Med J (1979) 0.75
Can the primary care physician be better trained in the psychosocial dimensions of patient care? Int J Psychiatry Med (1978) 0.75
Preparation of pentachlorophenol derivatives and development of a microparticle-based on-site immunoassay for the detection of PCP in soil samples. J Agric Food Chem (2001) 0.75
There's more than one way to flask a denture. NADL J (1974) 0.75
Communication breakdown between physicians and IBS sufferers: what is the conundrum and how to overcome it? J R Coll Physicians Edinb (2017) 0.75
Anorexia nervosa and bulimia: the eating disorders. Dis Mon (1985) 0.75
Implementation of the INTERGROWTH-21st Project in the United States. BJOG (2013) 0.75
Use of Markov modeling for evaluating the cost-effectiveness of immunosuppressive therapies in renal transplant recipients. Transplant Proc (1996) 0.75
Prospective economic evaluation accompanying a trial of GM-CSF/IL-3 in patients undergoing autologous bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. IL-3 BMT Study Team. Bone Marrow Transplant (1998) 0.75
Anorexia nervosa: a comprehensive approach. Adv Intern Med (1983) 0.75
A high-performance system for automation of the polymerase chain reaction. Biotechniques (1991) 0.75
Building a psychiatric-medical liaison: observations of the process. Psychiatr Med (1992) 0.75
The anti-trust suit against the AMA, 1939-1943: background for today's health planning. Soc Work Health Care (1978) 0.75